Without accurate diagnostics, it is difficult to talk about effective treatment of patients, especially in the case of cancer. Today, as much as 80% of diagnostic procedures using radiopharmaceuticals require the use of molybdenum-99. In the future, the production efficiency of this valuable radioisotope can be increased using uranium targets prepared by spatial printing.
Click here for original story, 3D printing can help produce valuable radiopharmaceuticals
Source: Phys.org